Percutaneous Tracheostomy Clinical Trial
Official title:
Use of Nerve Stimulation Technology to Aid in Percutaneous Tracheostomy in Intensive Care Patients.
Critically ill patients or patients under prolonged unconsciousness need a tube inserted into their windpipe to provide oxygen. This tube, called a tracheostomy tube, can be connected to a ventilation device to allow the patient to breathe when they cannot do it for themselves. In the hospital, doctors will perform a percutaneous tracheostomy (PT), where a needle is inserted through the skin of the neck into the windpipe, providing a guide for a tube that will dilate the tissue and create a hole that the tracheostomy tube can be inserted into. Although this is a common procedure in critical care units, it does carry some risks to the patient and is not always successful. The needle may puncture the back or side of the windpipe if it is inserted too far, or it can miss the windpipe altogether, causing damage to surrounding structures. We believe that doctors who perform PT would benefit from a method that improves the success rate of the procedure. We wish to test a device that alerts the doctor performing PT to when the needle tip is in the air-filled windpipe. The device has been proven to aid needle insertion in cadavers, but it needs to be tested on live patients. Since many intensive care patients undergo PT, we wish to test our technique on this population. It will be a controlled environment and the clinicians are experienced in PT. This technique should save valuable time, result in more accurate needle insertion, and lessen the risk of damaging other structures and tissues in the neck.
Background: Critically ill patients occasionally require a tracheostomy tube to breathe. A
percutaneous tracheostomy can be performed, where a needle/catheter is inserted into the
trachea, followed by insertion of a guidewire and a tube that dilates the tissue, creating a
hole for the tracheostomy tube. Although this is a common procedure, it does pose risks to
the patient, including accidental puncture of nearby structures. We wish to test a device
that alerts the doctor to when the needle tip is in the tracheal lumen. The device has been
proven to aid needle insertion in cadavers, but it needs to be tested on live patients. Since
many intensive care patients undergo PT, we wish to test our technique on this population.
Study objective: To evaluate the effectiveness of a nerve stimulator in aiding needle
tracheostomy in live patients.
Hypothesis: Nerve stimulation equipment will help the physician guide and insert the needle
tip into the tracheal lumen faster and with more accuracy than conventional techniques.
Primary outcome: speed and accuracy of needle tip placement in the trachea.
Procedure: This study will involve recruiting consenting adult patients from the University
of Alberta Hospital General Systems Intensive Care Unit (ICU) who require percutaneous
tracheostomy to insert a tracheal tube. In this population, a tracheostomy is usually
performed as a means to provide long-term assisted ventilation without the need for
endotracheal intubation. Briefly, the patient is sedated, the skin on their neck disinfected,
and a local anesthetic injected into the anterior neck. A bronchoscope is inserted down the
endotracheal tube to aid in visualization and localization of needle puncture. The
cricothyroid membrane is located by palpating the anterior neck and an incision is made over
the membrane. A small needle is inserted through the membrane to act as a guide for a larger
needle-catheter assembly. Both needles are removed and a guidewire is inserted through the
catheter. Using forceps, the insertion site is widened and a tube to dilate the opening is
inserted. The tracheostomy tube is then inserted and the dilation tube and guidewire are
removed. The endotracheal tube is removed and the ventilation apparatus is connected to the
tracheostomy tube.
We will supply ICU physicians with a commonly used nerve stimulator (Stimuplex HNS 12,
B.Braun, Germany) to attach to the needle-catheter assembly used to make the first insertion
into the trachea. The nerve stimulator will be connected to a current meter, and a ground
electrode will be attached to the body. When the needle tip is in contact with body tissue
(i.e., tracheal wall), the electrical circuit will be closed, producing a reading of 1.0 mA
on the current reader. Suspension of the needle tip in the airway will interrupt the circuit,
producing a reading of 0.0 mA. In addition, an audible signal built into the nerve stimulator
will alert the user to a change in current, warning that the needle tip has advanced too far
and is in contact with the posterior or lateral tracheal wall.
The physician will perform percutaneous tracheostomy on 20 ICU patients that require
endotracheal extubation and insertion of a tracheostomy tube. This will help support our
preliminary observations which showed that the nerve stimulator was helpful in guiding needle
insertion using human cadavers. By showing that the technique is equally as effective when
used on live patients, we can argue that a nerve stimulator or similar device can ensure
accurate, quick, and safe needle insertion when accessing the airway percutaneously.
Inclusion criteria: Adult; requires tracheostomy
Exclusion criteria: Failure to provide consent; known upper airway pathologies; known
oro-pharyngeal or laryngeal disease, including any swelling, tumour, or infection; previous
radiotherapy or operations on the neck; cervical spine fractures.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05834972 -
Ultrasound-guided Versus Landmark-guided Percutaneous Dilational Tracheostomy in Pediatric Patients
|
||
Recruiting |
NCT05416489 -
C-MAC Videolaryngoscopy Versus Direct Laryngoscopy for Percutaneous Tracheostomy
|
N/A | |
Completed |
NCT04188613 -
Use of High-Frequency Jet Ventilation During Percutaneous Tracheostomy
|
N/A |